Discover Great Companies Discover Great Clients
Popularity  26.2万   |   Followers  332   |   Likes  70   |   Feedback  258 Claim this company

Pharmaceutical Custom R&D and Manufacturing

No.18 Chongqing Popularity Ranking No.1 Changshou District No.1 Pharmaceutical APIs No.1 Zhong Jian Ti No.1 Raw Materials No.1 Biological Products No.1 APIs No.1 Pharmaceutical R&D No.1 Pharmaceutical No.1 Biopharmaceuticals No.1 Pharmaceutical Technology No.1 Peptides No.1 Sheng Wu Ke Ji / Biotechnology Engineering No.1 Pharmaceutical Industrial 企业技术中心 市级高新技术企业 高新技术企业 国家重点新产品 市级重点新产品 国家企业技术中心 PMDA认证 NMPA认证
More

Company Overview

  • Nature: Listed Company Size: 5000-9999 employees Founded: 21年
  • Industry: Pharmaceuticals/Bioengineering 、 Raw Materials and Processing
  • Full name: Porton Pharma Solutions Co., Ltd.。

Development Stage

  • Stage: IPO上市, 创业板, 深交所。
  • Ranking: Ranked #18 in Chongqing by popularity Ranked #1 in Chongqing Pharmaceutical APIs Company by popularity Ranked #1 in Chongqing Zhong Jian Ti Company by popularity Ranked #1 in Chongqing Raw Materials Company by popularity Ranked #1 in Chongqing Biological Products Company by popularity
  • Honors: 2023中国新经济500强 2024中国生命科学服务100强 企业技术中心 市级高新技术企业 According to algorithm
  • News: 2026-08-03:博腾股份:控股子公司取得药品生产许可证,已具备承接细胞与基因治疗产品商业化受托生产的合规资质。
  • Salary: 54.9% of positions earn 6-15K, In 2026 vs last yeargrew by 9%.。Master's salary: ¥24.8K, Doctorate salary: ¥33.2K.
  • R&D: "Biology/Pharmaceutical/Chemical/Environmental Protection" demand: 35.9%, "Other (R&D and Technical)": 27.9%, "Scientific Research": 15.2%。
  • Recruiting: In 2026 vs 2025grew by 112%. Demand for highly educated talent: Master's: 63, Doctorate: 6.
  • Requirement: Education: 本科 leads with 60.3%. Experience: 不限 leads with 29.7%.
  • Region: Distributed across 6 regions, 上海: 40.6%, 重庆: 39.5%, 宜春: 8.2%, 孝感: 5.2%.

About the Company

[Summary] Pharmaceutical Custom R&D and Manufacturing

Chongqing Porton Pharma Solutions Co., Ltd. was established in 2005 and is a leading domestic contract development and manufacturing organization (CDMO) for pharmaceuticals. In 2014, it was listed on the Shenzhen Stock Exchange (stock code: 300363). The company primarily provides global pharmaceutical companies and drug R&D institutions with custom R&D and manufacturing services for chemical drugs, biologics, and formulations throughout the entire drug lifecycle, from early clinical research to market launch. As a national high-tech enterprise, we offer world-class end-to-end CDMO services to global clients. Our R&D, manufacturing, and operations span across Chongqing, Chengdu, Shanghai, Jiangxi, Suzhou, Hong Kong (China), the United States, Belgium, Switzerland, and the United Kingdom, with over 3,000 employees worldwide.
We are committed to becoming the world's most open, innovative, and reliable pharmaceutical service platform, enabling better medicines to benefit the public sooner. Through over a decade of dedication, we have built strong R&D technology platforms, comprehensive quality management, EHS management systems, and a proven delivery record. We provide core services to global innovative drug companies, ranging from pilot-scale to commercial production and various certification, registration, and approval support. We have passed NMPA, FDA, PMDA, WHO, and EMA certifications, serving renowned pharmaceutical companies and drug R&D institutions worldwide. Our product portfolio includes blockbuster drugs with annual global sales exceeding $1 billion, covering therapeutic areas such as AIDS, hepatitis, diabetes, tumors, pain management, heart failure, blood lipid lowering, insomnia, epilepsy, influenza, and allergies.
We persist in driving high-quality development through technological innovation, continuously increasing R&D investment, and actively advancing key core technology development and the cultivation of innovative talent teams. In 2020, R&D investment reached RMB 158 million, with an R&D team exceeding 700 members. As of the end of 2020, the company had been granted 40 invention patents (31 domestic and 9 international) and 4 PCT patents.
We leverage over a decade of experience in serving multinational pharmaceutical companies and our internationally excellent CDMO platform to actively support domestic drug development and accelerate the drug approval process. We provide comprehensive services to domestic pharmaceutical companies and drug R&D institutions, including innovative drug CMC services, MAH commissioned manufacturing, clinical trial services, custom R&D and manufacturing of innovative drug intermediates, APIs, and formulations, as well as gene and cell therapy CDMO services. We are progressively building an open, collaborative CDMO platform that excels in both "technological innovation" and "service innovation."

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Porton Pharma Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 创业板
  • Deal: 深交所

Porton Pharma How Fast Is Hiring Growing? (443 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 92%
  • 2024: Down 58%
  • 2023: Down 30%
  • 2022: Up 92%
Porton Pharma Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Porton Pharma Campus Recruitment & Advanced Degree Talent Demand
Graduates 10 Interns 12 Master's 63 Doctorate 6
Note: How fast is hiring at Porton Pharma Solutions Co., Ltd. growing? Porton Pharma2026: 917 openings (up 112%), 2025: 432 openings (up 92%), 2024: 225 openings (down 58%), 2023: 534 openings (down 30%), 2022: 762 openings (up 92%), 2021: 396 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Porton Pharma Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 400%
  • 2024: Down 88%
  • 2023: Up 57%
  • 2022: Up 45%
Porton Pharma Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Porton Pharma Solutions Co., Ltd. growing? Porton PharmaMaster's recruitment over the years: 2025: 40 openings (up 400%), 2024: 8 openings (down 88%), 2023: 66 openings (up 57%), 2022: 42 openings (up 45%), 2021: 29 openings. Porton Pharma master talent ranking in Chongqing: #7, Porton Pharma master salary mostly around 15-30K.

Porton Pharma Doctoral Degree Job Demand Analysis

(More)
+58%
Growth Rate
2026 vs 2025
  • 2025: Up 500%
  • 2024: Down 88%
  • 2023: Up 45%
  • 2022: Up 57%
Porton Pharma Doctoral Hiring by Year: 2026 — 7 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Porton Pharma Solutions Co., Ltd. growing? Porton PharmaDoctorate recruitment over the years: 2026: 19 openings (up 58%), 2025: 12 openings (up 500%), 2024: 2 openings (down 88%), 2023: 16 openings (up 45%), 2022: 11 openings (up 57%), 2021: 7 openings. Porton Pharma doctorate talent ranking in Chongqing: #15, Porton Pharma doctorate salary mostly around 20-50K.

Porton Pharma R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Porton Pharma Solutions Co., Ltd.? Based on an analysis of Porton Pharma's job postings over the past year, "Biology/Pharmaceutical/Chemical/Environmental Protection" demand: 35.9%, "Other (R&D and Technical)": 27.9%, "Scientific Research": 15.2%, "Computer/Network/Technology": 5.1%, "Medical & Health/Beauty & Healthcare": 4.9%, "Mechanical/Instrumentation": 4.3%. For reference only.

Porton Pharma — What Are the Salaries Like? (922 records)

Manage
salary range: 4.5K - 50K, 54.9% of roles pay ¥6-15K
Note: salary statistics are based on 922 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Porton Pharma Solutions Co., Ltd.?Porton Pharma54.9% of positions earn 6-15K, Fresh graduate salary: ¥13.2K。Chongqing salary ranking top 15,生物/制药/化工/环保类 average salary ¥17.3K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Porton Pharma

(More)
Are salaries high at Porton Pharma Solutions Co., Ltd.? We provide: Researcher, QA, Analyst, QC, Production Worker, Process Engineer, Operations, Synthesis Engineer, Inspector, Intern, Operator, Procurement, Project Management, ehs, DM, Customer Service, Security Officer, Product Manager, Project Manager, Verification Engineer. Click to view detailed salary analysis by job.

Porton Pharma — Fortune 500? (More)

Yes, ranked in 中国新经济500强:

  • NO.358 2023中国新经济500强 >
  • NO.180 2022中国新经济500强 >
  • NO.184 2021中国新经济500强 >

Yes, ranked in 中国生命科学服务100强:

  • NO.13 2024中国生命科学服务100强 >
  • NO.21 2023中国生命科学服务100强 >
  • NO.14 2022中国生命科学服务100强 >

Job Category

  • 生物/制药/化工/环保类
    36.6% of total 36.6%
  • 工厂生产类
    31.3% of total 31.3%
  • 其他(研发和技术类)
    28.2% of total 28.2%
  • 质量管理类
    20.7% of total 20.7%

Education

  • 本科
    60.3% of total 60.3%
  • 硕士
    13.1% of total 13.1%
  • 大专
    11.9% of total 11.9%
  • 不限
    9.1% of total 9.1%

Experience

  • 不限
    29.7% of total 29.7%
  • 1-3年
    26% of total 26%
  • 5-10年
    20.2% of total 20.2%
  • 3-5年
    17.7% of total 17.7%
View Detailed Analysis

What does Porton Pharma Solutions Co., Ltd. require? Who is Porton Pharma hiring? Porton Pharma recruitment: 生物/制药/化工/环保类占比最多占36.6%,其次是工厂生产类占31.3%. What education can get in at Porton Pharma? 本科占比最多占60.3%,其次是硕士占13.1%. High education required at Porton Pharma? 硕士占13.1%,博士占2%. Work experience required at Porton Pharma? 不限占比最多占29.7%,其次是1-3年占26%. Where are the job locations at Porton Pharma? 上海占比最多占40.6%,其次是重庆占39.5%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 54,344.2176万(元)
Legal Representative: 居年丰
Date Established:
Credit Code: 915000007748965415
Registered Address: 重庆市(长寿)化工园区精细化工一区

Partners & Suppliers

汉德创宏为博腾股份提供化学合成服务 Source
供应商 CRO/CDMO客户
大连双硼为博腾股份提供定制化硼中间体 Source
供应商 医药中间体
提供原料药定制生产 Source
合作客户 药物生产外包(CDMO)
公司向其提供多肽合成试剂及分子砌块,为CDMO领域重要客户 Source
供应商 CRO/CDMO
2022年3月,海思科与博腾股份签署战略合作框架协议,由博腾股份作为CDMO为海思科提供原料药及制剂生产服务。 Source
合作客户 药物研发外包服务(CRO/CDMO)

People who follow Porton Pharma also follow

Porton Pharma Competitors (Similar Companies)

“For many consecutive years, it has maintained a leading position in do”
“To provide patients with trustworthy and affordable innovative biologi”
“Virtue over the world, medicine benefits all”
“Serving human pharmaceutical and health undertakings”
“The company is a group pharmaceutical enterprise integrating R&D, prod”
“Driving automotive energy transformation, creating a smart mobile life”
“Primarily engaged in the research and development, production, and sal”
化工/化学 工程设计 甲醇 乙酰
化工/化学 化学品 浮选剂 溶剂
“Be a good person, produce good medicine.”
“Technological innovation and commercial application of pharmaceutical ”
“Custom chemical synthesis, pharmaceutical intermediates, and new drug ”
“Key pharmaceutical enterprise in Chongqing”
医药 药物研发 医药服务 医药工业
“Leading enterprise in biomedical R&D, production, and export in Wester”

Discover Great Companies, Discover Great Clients

重庆公司名录 重庆“Changshou District”公司名录 重庆“医药”公司名录 重庆“制药/药业”公司名录 重庆“生物制药”公司名录 重庆“医药中间体”公司名录 重庆“创新药”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates